Search Results - "Katz, Seymour"

Inflammatory Bowel Disease of the Elderly: Frequently Asked Questions (FAQs) by KATZ, Seymour, PARDI, Darrell S

“…The growing recognition of the older inflammatory bowel disease (IBD) patient is heightened by the entry of the 77.2 million baby boomers who will turn 65…”
Get full text

The elderly IBD patient in the modern era: changing paradigms in risk stratification and therapeutic management by Hong, Simon J., Katz, Seymour

“…The incidence and prevalence of inflammatory bowel disease (IBD) is rising in the elderly population. Compared with patients with onset during their younger…”
Get full text

Teduglutide, a novel mucosally active analog of glucagon‐like peptide‐2 (GLP‐2) for the treatment of moderate to severe Crohn's disease by Buchman, Alan L., Katz, Seymour, Fang, John C., Bernstein, Charles N., Abou‐Assi, Souheil G.

“…Background: Teduglutide, an analog of glucagon‐like peptide‐2 (GLP‐2), is associated with trophic effects on gut mucosa. Its role in the treatment of active…”
Get full text

My Treatment Approach to the Management of Ulcerative Colitis by Katz, Seymour, MD, MACG

“…Abstract Ulcerative colitis diagnosis and management represent a challenge for clinicians. The disguises of ischemia and acute infectious colitis continue to…”
Get full text

A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci by Kenny, Eimear E, Pe'er, Itsik, Karban, Amir, Ozelius, Laurie, Mitchell, Adele A, Ng, Sok Meng, Erazo, Monica, Ostrer, Harry, Abraham, Clara, Abreu, Maria T, Atzmon, Gil, Barzilai, Nir, Brant, Steven R, Bressman, Susan, Burns, Edward R, Chowers, Yehuda, Clark, Lorraine N, Darvasi, Ariel, Doheny, Dana, Duerr, Richard H, Eliakim, Rami, Giladi, Nir, Gregersen, Peter K, Hakonarson, Hakon, Jones, Michelle R, Marder, Karen, McGovern, Dermot P B, Mulle, Jennifer, Orr-Urtreger, Avi, Proctor, Deborah D, Pulver, Ann, Rotter, Jerome I, Silverberg, Mark S, Ullman, Thomas, Warren, Stephen T, Waterman, Matti, Zhang, Wei, Bergman, Aviv, Mayer, Lloyd, Katz, Seymour, Desnick, Robert J, Cho, Judy H, Peter, Inga

“…Crohn's disease (CD) is a complex disorder resulting from the interaction of intestinal microbiota with the host immune system in genetically susceptible…”
Get full text

Fontolizumab in moderate to severe Crohn's disease: A phase 2, randomized, double‐blind, placebo‐controlled, multiple‐dose study by Reinisch, Walter, de Villiers, Williem, Bene, László, Simon, László, Rácz, István, Katz, Seymour, Altorjay, István, Feagan, Brian, Riff, Dennis, Bernstein, Charles N., Hommes, Daniel, Rutgeerts, Paul, Cortot, Antoine, Gaspari, Michael, Cheng, May, Pearce, Tillman, Sands, Bruce E.

“…Background: The safety and efficacy of fontolizumab, a humanized anti‐interferon gamma antibody, was investigated in patients with Crohn's disease (CD)…”
Get full text

Pulmonary manifestations of inflammatory bowel disease by Storch, Ian, Sachar, David, Katz, Seymour

“…Extraintestinal manifestations of both Crohn's disease and ulcerative colitis (UC) have been well described, although pulmonary findings are often overlooked…”
Get full text

Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial by Sandborn, William J., Hanauer, Stephen B., Katz, Seymour, Safdi, Michael, Wolf, Douglas G., Baerg, Richard D., Tremaine, William J., Johnson, Therese, Diehl, Nancy N., Zinsmeister, Alan R.

“…Background & Aims: We evaluated etanercept, a human soluble tumor necrosis factor receptor: Fc fusion protein, for the treatment of active Crohn's disease…”
Get full text

Chronic appendicitis: uncommon cause of chronic abdominal pain by Kothadia, Jiten P., Katz, Seymour, Ginzburg, Lev

Get full text

Risk factors for incomplete telehealth appointments among patients with inflammatory bowel disease by Stone, Katherine L., Kulekofsky, Emma, Hudesman, David, Kozloff, Samuel, Remzi, Feza, Axelrad, Jordan E., Katz, Seymour, Hong, Simon J., Holmer, Ariela, McAdams-DeMarco, Mara A., Segev, Dorry L., Dodson, John, Shaukat, Aasma, Faye, Adam S.

“…Background: The COVID-19 pandemic led to the urgent implementation of telehealth visits in inflammatory bowel disease (IBD) care; however, data assessing…”
Get full text

Ileal Adenocarcinoma with Liver Metastasis in Patient with Crohn’s Disease: A 9-Year Survival by Itzkowitz, Steven H., Bruckner, Howard, Katz, Seymour, Nagaraju, Deepa H., Kothadia, Jiten P., Schwartz, Myron

“…Small bowel adenocarcinoma is a rare but well-known complication of Crohn’s disease. The diagnosis of small bowel adenocarcinoma remains difficult since its…”
Get full text

Ileal Diverticulitis as a Cause of Right Lower Quadrant Pain: A Case Report and Review of the Literature by Jiten P. Kothadia, Seymour Katz, Lev Ginzburg

“…Introduction Small bowel diverticulitis is a rare clinical disease of the small bowel. The incidence of small bowel diverticulitis varies from 0.3 to 2.3 % in…”
Get full text

Endoscopy in the Elderly by Razavi, Farid, MD, Gross, Seth, MD, Katz, Seymour, MD

“…There has been limited research examining the risks, benefits, and use of common endoscopic procedures in the elderly. Furthermore, gastroenterology training…”
Get full text

Acute Pancreatitis in a Patient With Ulcerative Colitis on Vedolizumab by Lin, Elissa, Katz, Seymour

“…Vedolizumab is a humanized monoclonal antibody that is approved for treatment of patients with moderate to severe ulcerative colitis and is thought to be both…”
Get full text

Therapeutic Use of Cannabis in Inflammatory Bowel Disease by Ahmed, Waseem, Katz, Seymour

“…The marijuana plant and its derivatives, cannabinoids, have grown increasingly popular as a potential therapy for inflammatory bowel disease (IBD). Studies…”
Get full text

S3940 Mimicry and Deception in CMUSE by Luke, Naveena, Katz, Seymour

Get full text

Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease by Sands, Bruce E., Bank ‡, Simmy, Sninsky §, Charles A., Robinson ∥, Malcolm, Katz ¶, Seymour, Singleton #, John W., Miner, Philip B., Safdi, Michael A., Galandiuk ‡‡, Susan, Hanauer §§, Stephen B., Varilek ∥∥, Gary W., Buchman ¶¶, Alan L., Rodgers ##, Vance D., Salzberg, Bruce, Cai ‡‡, Bin, Loewy ‡‡‡, John, DeBruin ‡‡‡, Michael F., Rogge ‡‡‡, Holly, Shapiro ‡‡‡, Mark, Schwertschlag ‡‡‡, Ullrich S.

“…Background & Aims: Recombinant human interleukin 11 (rhIL-11) is a cytokine with thrombocytopoietic activity and anti-inflammatory and mucosal protective…”
Get full text

Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease by LIH-BRODY, L, POWELL, S. R, FISHER, S. E, MULLIN, G. E, COLLIER, K. P, REDDY, G. M, CERCHIA, R, KAHN, E, WEISSMAN, G. S, KATZ, S, FLOYD, R. A, MCKINLEY, M. J

“…Inflammatory bowel disease (IBD) is characterized by chronic intestinal inflammation whose cellular components are capable of oxidative respiratory bursts that…”
Get full text

S3183 Obstructive Gastrointestinal Neuroectodermal Tumor in a Patient With Ulcerative Colitis by She, Tianyu, Katz, Seymour

Get full text

An Unusual Case of Intestinal Spirochetosis in a Patient with Ulcerative Colitis: 3002 by Liu, Yingheng, Katz, Seymour

“…Intestinal Spirochetosis (IS) is an uncommon condition in which spirochetes colonize the colorectal epithelium. The clinical and pathological significance of…”
Get full text